Select login type
xCHOOSE A PAGE TO ACCESS
x- WGXI Patient Involvement: Workplans, drafts, TC notes ...
- WGXI Patient Involvement: Background Documents
- WGXI Patient Involvement: Face-to-face meetings
- WGXII Benefit-risk Working Group Documents
- WGXII Benefit-risk Working Group Documents
- WGXIII Real-world Data Working Group Documents
- SCAR Working Group Documents
- Educational Standards Working Group Documents
- Good Governance Practice for Research Institutions Working Group Documents
- Pharmacoepidemiology for Public Health Working Group Documents
- MedDRA Labelling Groupings Working Group Documents
- Clinical Research in Resource-limited Settings Working Group Documents
- Login
News
03
Jun
Medicines assessment during public health emergencies needs good science, best practices and proper communication
Statement from the CIOMS International Expert Working Group on Benefit-Risk Balance for Medicinal Products